BRISTOL, Tenn., Feb. 18 /PRNewswire-FirstCall/ -- King Pharmaceuticals,
Inc. (NYSE: KG) reported today that the Company will provide a live webcast of
its conference call to be held following King's announcement of earnings for
the fourth quarter and year ending December 31, 2003. As previously
announced, King plans to announce earnings for the fourth quarter and year
ending December 31, 2003, prior to the market open on Thursday, February 19,
2004.
Interested persons may listen to the live conference call on Thursday,
February 19, 2004, at 1:00 p.m., E.S.T.
at http://www.firstcallevents.com/service/ajwz399300393gf12.html or by dialing
800-245-3043 (U.S. only) or 785-832-1508 (international), passcode KG. If you
are unable to participate during the live webcast, the call will be archived
on King's web site http://www.kingpharm.com for not less than 30 days following the
call. A replay of the conference call will also be available for not less
than 30 days following the call by dialing 888-274-8335 (U.S. only) or
402-220-2327 (international).
(Minimum requirements to listen to the broadcast: The Windows Media Player
software, downloadable free
from http://www.microsoft.com/windows/windowsmedia/EN/default.asp , and at
least a 28.8 Kbps connection to the internet. If you experience problems
listening to the broadcast, send an email to webcastsupport@tfprn.com).
About King Pharmaceuticals
King, headquartered in Bristol, Tennessee, is a vertically integrated
branded pharmaceutical company. King, an S&P 500 Index company, seeks to
capitalize on opportunities in the pharmaceutical industry through the
development, including through in-licensing arrangements and acquisitions, of
novel branded prescription pharmaceutical products in attractive markets and
the strategic acquisition of branded products that can benefit from focused
promotion and marketing and product life-cycle management.
This release contains forward-looking statements which reflect
management's current views of future events and operations, including, but not
limited to, statements pertaining to the anticipated date for release of the
Company's financial results for the fourth quarter and year ending December
31, 2003 and the live webcast of the conference call following the release.
These forward-looking statements involve certain significant risks and
uncertainties, and actual results may differ materially from the
forward-looking statements. Some important factors which may cause results to
differ include: dependence on King's ability to release the Company's
financial results for fourth quarter and year ending December 31, 2003, and
conduct its conference call as currently planned on February 19, 2004. Other
important factors that may cause actual results to differ materially from the
forward-looking statements are discussed in the "Risk Factors" section and
other sections of King's Form 10-K for the year ended December 31, 2002 and
Form 10-Q for the third quarter ended September 30, 2003, which are on file
with the Securities and Exchange Commission. King does not undertake to
publicly update or revise any of its forward-looking statements even if
experience or future changes show that the indicated results or events will
not be realized.
SOURCE King Pharmaceuticals, Inc.
 back to top
Related links:
http://www.kingpharm.com
Audio:http://www.firstcallevents.com/service/ajwz399300393gf12.html
CONTACT:
James E. Green, Executive Vice President,
Corporate Affairs of King Pharmaceuticals, Inc., +1-423-989-8125
|
